Could Vaccine Dose Stretching Reduce COVID-19 Deaths? Witold Wiecek, Amrita Ahuja, Michael Kremer, Alexandre Simoes Gomes, Christopher M. Snyder, Alex Tabarrok, and Brandon Joel Tan Abstract We argue that alternative COVID-19 vaccine dosing regimens could potentially dramatically accelerate global COVID-19 vaccination and reduce mortality, and that the costs of testing these regimens are dwarfed […]
BREAD Working Paper No. 530, November 2017
Preventives Versus Treatments Redux: Tighter Bounds on Distortions in Innovation Incentives with an Application to the Global Demand for HIV Pharmaceuticals Michael Kremer, Christopher M. Snyder Abstract Kremer and Snyder (2015) show that demand curves for a preventive and treatment may have different shapes though they target the same disease, biasing the pharmaceutical manufacturer toward […]
BREAD Working Paper No. 544, September 2018
Worst-Case Bounds on R&D and Pricing Distortions: Theory and Disturbing Conclusions if Consumer Values Follow the World Income Distribution Michael Kremer, Christopher M. Snyder Abstract We prove that, for general demand and cost conditions and market structures, the fraction of first- best surplus that a monopolist is unable to extract in a market provides a […]
BREAD Working Paper No. 574, March 2020
Optimal Subsidies for Prevention of Infectious Disease Matthew Goodkin-Gold, Michael Kremer, Christopher M. Snyder, Heidi Williams Abstract Most economists would agree that the positive externalities caused by prevention of infectious disease create a prima facie case for subsidies. However, little is known about the appropriate magnitude of these subsidies, or about whether the level of […]